Mahalo

Mahalo Health develops a unified digital health platform designed to accelerate both digital health app development and clinical research. The platform serves healthcare innovators, life sciences companies, and clinical researchers, enabling them to launch patient-centric digital health applications and conduct clinical trials in weeks rather than months or years.

The platform is structured around two primary accelerators: a Digital Health App Accelerator and a Clinical Research Accelerator. Both are built on prebuilt, configurable modules that allow organizations to focus on therapeutic content and patient engagement rather than custom software development from scratch.

Digital Health App Accelerator

• Enables rapid deployment of white-label digital health apps configured in weeks, following patient experience best practices.
• Organizations incorporate content and workflows from their own therapeutic area of expertise into the prebuilt framework.
• Prebuilt modules include: microlearning, telemedicine, text chat, chatbot, payment processing, patient self-scheduling, connected device integration, health assessments, health scores, questionnaires, medication management, decision support systems, remote patient monitoring, and disease detectors.
• Designed to address the reality that 96% of digital health apps fail, by reducing development time and allowing teams to focus on personalizing content that improves patient outcomes.

Clinical Research Accelerator

• Provides a customizable clinical trial platform aimed at reducing study timelines and costs.
• Supports expedited study startup, patient recruitment, and screening processes.
• Includes automations such as EHR integrations and patient self-scheduling to reduce labor-intensive tasks and associated costs.
• Integrates with over 260 connected devices, enabling real-time biomarker data collection directly from ePRO systems or digital health apps.
• Designed to improve patient adherence and researcher experience throughout the trial lifecycle.

Compliance and Security

• Mahalo Health is ISO 27001 and ISO 9001 certified.
• The platform adheres to FDA 21 CFR Part 11, ICH E6 GCP, GDPR, and HIPAA guidelines.
• Compliance documentation includes Good Clinical Practice (GCP) certificates, HIPAA compliance certificates, GDPR statements, and a responsible disclosure policy.

Platform and Product Areas

• Products span eClinical, DTx (digital therapeutics) development, and a unified data platform.
• Coverage extends across multiple therapeutics areas.
• The platform is available to organizations across the Americas, Europe, Middle East, Africa, and Asia-Pacific regions.

Mahalo Health positions itself as the first unified platform combining digital health app development and clinical research acceleration. Customers include organizations such as MyHealthierBrain, whose CEO noted that Mahalo's prebuilt accelerators provided a more efficient path to market than custom coding for a cognitive health application.